Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2014 1
2016 3
2017 3
2019 2
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study).
Giommoni E, Maiello E, Vaccaro V, Rondini E, Vivaldi C, Tortora G, Toppo L, Giordano G, Latiano TP, Lamperini C, Pillozzi S, Boni L, Antonuzzo L, Di Costanzo F. Giommoni E, et al. Among authors: toppo l. Curr Oncol. 2021 May 8;28(3):1761-1772. doi: 10.3390/curroncol28030164. Curr Oncol. 2021. PMID: 34066784 Free PMC article. Clinical Trial.
Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression: Lesson Learned for Future Trials With EGFR/MET Dual Inhibition.
Rimassa L, Bozzarelli S, Pietrantonio F, Cordio S, Lonardi S, Toppo L, Zaniboni A, Bordonaro R, Di Bartolomeo M, Tomasello G, Dadduzio V, Tronconi MC, Piombo C, Giordano L, Gloghini A, Di Tommaso L, Santoro A. Rimassa L, et al. Among authors: toppo l. Clin Colorectal Cancer. 2019 Jun;18(2):125-132.e2. doi: 10.1016/j.clcc.2019.02.004. Epub 2019 Feb 14. Clin Colorectal Cancer. 2019. PMID: 30846365 Clinical Trial.
Safety and efficacy of dose-dense chemotherapy with TCF regimen in elderly patients with locally advanced or metastatic gastric cancer.
Liguigli W, Tomasello G, Toppo L, Poli R, Lazzarelli S, Negri F, Perrucci B, Curti A, Brighenti M, Donati G, Nazzari M, Martinotti M, Vismarra M, Rovatti M, Passalacqua R. Liguigli W, et al. Among authors: toppo l. Tumori. 2017 Jan 21;103(1):93-100. doi: 10.5301/tj.5000556. Epub 2016 Aug 23. Tumori. 2017. PMID: 27647222 Clinical Trial.
First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5-fluorouracil (DCF) plus panitumumab in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction: final results and biomarker analysis from an Italian oncology group for clinical research (GOIRC) phase II study.
Tomasello G, Valeri N, Ghidini M, Smyth EC, Liguigli W, Toppo L, Mattioli R, Curti A, Hahne JC, Negri FM, Panni S, Ratti M, Lazzarelli S, Gerevini F, Colombi C, Panni A, Rovatti M, Treccani L, Martinotti M, Passalacqua R. Tomasello G, et al. Among authors: toppo l. Oncotarget. 2017 Dec 4;8(67):111795-111806. doi: 10.18632/oncotarget.22909. eCollection 2017 Dec 19. Oncotarget. 2017. PMID: 29340092 Free PMC article.
Novel role of triazenes in haematological malignancies: pilot study of Temozolomide, Lomeguatrib and IL-2 in the chemo-immunotherapy of acute leukaemia.
Caporaso P, Turriziani M, Venditti A, Marchesi F, Buccisano F, Tirindelli MC, Alvino E, Garbin A, Tortorelli G, Toppo L, Bonmassar E, D'Atri S, Amadori S. Caporaso P, et al. Among authors: toppo l. DNA Repair (Amst). 2007 Aug 1;6(8):1179-86. doi: 10.1016/j.dnarep.2007.03.016. Epub 2007 May 17. DNA Repair (Amst). 2007. PMID: 17500047